Modernization of chemical risk assessment to make use of novel toxicological data.
作者信息
Mortensen Holly M.
机构信息
U.S. Environmental Protection Agency, Office of Research and Development, Center for Public Health and Environmental Assessment, Public Health and Integrated Toxicology Division, Clinical Research Branch.
出版信息
Toxicol Appl Pharmacol. 2020 May 1;394:114951. doi: 10.1016/j.taap.2020.114951. Epub 2020 Mar 18.
Abstract
摘要
相似文献
1
Modernization of chemical risk assessment to make use of novel toxicological data.利用新型毒理学数据实现化学风险评估的现代化。
Toxicol Appl Pharmacol. 2020 May 1;394:114951. doi: 10.1016/j.taap.2020.114951. Epub 2020 Mar 18.
2
Current trends in toxicological risk assessment: perspectives from the committee on toxicology.
Inhal Toxicol. 1999 Jun-Jul;11(6-7):459-76. doi: 10.1080/089583799196871.
3
Applying simulation modeling to problems in toxicology and risk assessment--a short perspective.将模拟建模应用于毒理学和风险评估问题——简要展望。
Toxicol Appl Pharmacol. 1995 Aug;133(2):181-7. doi: 10.1006/taap.1995.1140.
4
The long and winding road of progress in the use of in vitro data for risk assessment purposes: From "carnation test" to integrated testing strategies.将体外数据用于风险评估目的的漫长而曲折的发展历程：从“康乃馨试验”到综合测试策略。
Toxicology. 2015 Jun 5;332:4-7. doi: 10.1016/j.tox.2014.04.004. Epub 2014 Apr 24.
5
Toxicogenomic profiling of chemically exposed humans in risk assessment.化学暴露人群的毒理基因组学分析在风险评估中的应用。
Mutat Res. 2010 Dec;705(3):172-83. doi: 10.1016/j.mrrev.2010.04.001. Epub 2010 Apr 9.
6
The new tapestry of risk assessment.风险评估的新图景。
Neurotoxicology. 2008 Sep;29(5):883-90. doi: 10.1016/j.neuro.2008.04.004. Epub 2008 Apr 20.
7
5 Steps toward an evidence-based toxicology: 5.1 evidence-based tools in toxicological basic research.迈向循证毒理学的5个步骤：5.1毒理学基础研究中的循证工具。
Hum Exp Toxicol. 2009 Feb;28(2-3):151. doi: 10.1177/0960327109105777.
8
Toward an evidence-based toxicology.迈向基于证据的毒理学。
Hum Exp Toxicol. 2006 Sep;25(9):497-513. doi: 10.1191/0960327106het648oa.
9
Science and decisions: advancing toxicology to advance risk assessment.科学与决策：推进毒理学以促进风险评估
Toxicol Sci. 2013 Jan;131(1):1-8. doi: 10.1093/toxsci/kfs246. Epub 2012 Aug 8.
10
Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.毒理学中基因组学数据的当前和未来应用：监管应用的机遇和挑战。
Regul Toxicol Pharmacol. 2011 Nov;61(2):141-53. doi: 10.1016/j.yrtph.2011.07.012. Epub 2011 Aug 5.
本文引用的文献
1
The 2021 update of the EPA's adverse outcome pathway database.美国环保署（EPA）不良结局路径数据库 2021 年更新版。
Sci Data. 2021 Jul 12;8(1):169. doi: 10.1038/s41597-021-00962-3.
2
Integrating adverse outcome pathways (AOPs) and high throughput in vitro assays for better risk evaluations, a study with drug-induced liver injury (DILI).整合不良结局途径（AOP）和高通量体外检测方法以更好地进行风险评估，以药物性肝损伤（DILI）为例的研究。
ALTEX. 2020;37(2):187-196. doi: 10.14573/altex.1908151. Epub 2019 Nov 8.
3
Mining Public Toxicogenomic Data Reveals Insights and Challenges in Delineating Liver Steatosis Adverse Outcome Pathways.挖掘公共毒理基因组学数据揭示了在描绘肝脂肪变性不良结局途径方面的见解与挑战。
Front Genet. 2019 Oct 18;10:1007. doi: 10.3389/fgene.2019.01007. eCollection 2019.
4
Identification of differentially expressed genes and networks related to hepatic lipid dysfunction.鉴定与肝脂功能障碍相关的差异表达基因和网络。
Toxicol Appl Pharmacol. 2019 Nov 1;382:114757. doi: 10.1016/j.taap.2019.114757. Epub 2019 Sep 11.
5
Population-based toxicity screening in human induced pluripotent stem cell-derived cardiomyocytes.基于人群的毒性筛选在人诱导多能干细胞衍生的心肌细胞中。
Toxicol Appl Pharmacol. 2019 Oct 15;381:114711. doi: 10.1016/j.taap.2019.114711. Epub 2019 Aug 16.
6
The use of evidence from high-throughput screening and transcriptomic data in human health risk assessments.高通量筛选和转录组数据在人类健康风险评估中的应用。
Toxicol Appl Pharmacol. 2019 Oct 1;380:114706. doi: 10.1016/j.taap.2019.114706. Epub 2019 Aug 7.
7
Identification of potential endocrine disrupting chemicals using gene expression biomarkers.利用基因表达标志物鉴定潜在的内分泌干扰化学物质。
Toxicol Appl Pharmacol. 2019 Oct 1;380:114683. doi: 10.1016/j.taap.2019.114683. Epub 2019 Jul 17.
8
Determination of chemical-disease risk values to prioritize connections between environmental factors, genetic variants, and human diseases.确定化学疾病风险值，以优先考虑环境因素、遗传变异体与人类疾病之间的关联。
Toxicol Appl Pharmacol. 2019 Sep 15;379:114674. doi: 10.1016/j.taap.2019.114674. Epub 2019 Jul 16.
9
Developing novel in vitro methods for the risk assessment of developmental and placental toxicants in the environment.开发用于评估环境中发育和胎盘毒物的新型体外方法。
Toxicol Appl Pharmacol. 2019 Sep 1;378:114635. doi: 10.1016/j.taap.2019.114635. Epub 2019 Jun 22.
10
Transcriptomic points-of-departure from short-term exposure studies are protective of chronic effects for fish exposed to estrogenic chemicals.转录组学从短期暴露研究中的出发点是保护鱼类免受暴露于雌激素类化学物质的慢性影响。
Toxicol Appl Pharmacol. 2019 Sep 1;378:114634. doi: 10.1016/j.taap.2019.114634. Epub 2019 Jun 19.
Zotero 插件